US-China Fentanyl Crisis: Tariff Adjustments Amid Ongoing Negotiations

The US has reduced tariffs on Chinese products related to synthetic opioids from 20% to 10% following China's commitment to curb fentanyl precursor exports. Despite a decline in overdose deaths, experts warn that the situation remains precarious, with nearly 40,000 deaths attributed to synthetic opioids in 2025. Former officials express skepticism about the effectiveness of China's measures, citing a lack of serious action. The US continues to hold China accountable for its role in the fentanyl crisis, while negotiations have stalled since October 2025. The decline in overdose deaths may be linked to a supply shock from China, affecting the purity of fentanyl. However, the exact impact of China's interventions remains uncertain. The geopolitical tension surrounding drug trafficking persists, complicating US-China relations.

Key Points: • US reduced tariffs on Chinese fentanyl precursors from 20% to 10% as part of negotiations. • Approximately 40,000 deaths from synthetic opioids occurred in 2025, despite a decline in overall overdose deaths. • Experts question the effectiveness of China's commitments to control fentanyl exports.